MedPath

Phase II study of single fraction HDR combined with whole pelvic IMRT for prostate cancer

Phase 2
Recruiting
Conditions
prostate cancer
Registration Number
JPRN-UMIN000021645
Lead Sponsor
Department of Radiation Oncology, National Cancer Center Hospital, Japan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
27
Inclusion Criteria

Not provided

Exclusion Criteria

1.Synchronous malignancies 2.Past medical history of pelvic radiotherapy 3.Past medical history of surgery, HIFU, and chemotherapy for prostate cancer 4.Inflammatory bowel disease such as Crohn disease or ulcerative colitis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath